Failure of ductus arteriosus closure and remodeling in neonatal mice deficient in cyclooxygenase-1 and cyclooxygenase-2.

The transition to pulmonary respiration following birth requires rapid alterations in the structure of the mammalian cardiovascular system. One dramatic change that occurs is the closure and remodeling of the ductus arteriosus (DA), an arterial connection in the fetus that directs blood flow away from the pulmonary circulation. A role for prostaglandins in regulating the closure of this vessel has been supported by pharmacological and genetic studies. The production of prostaglandins is dependent on two cyclooxygenases (COX-1 and COX-2), which are encoded by separate genes. We report here that the absence of either or both COX isoforms in mice does not result in premature closure of the DA in utero. However, 35% of COX-2(-/-) mice die with a patent DA within 48 h of birth. In contrast, the absence of only the COX-1 isoform does not affect closure of the DA. The mortality (35%) and patent DA incidence due to absence of COX-2 is, however, significantly increased (79%) when one copy of the gene encoding COX-1 is also inactivated. Furthermore, 100% of the mice deficient in both isoforms die with a patent DA within 12 h of birth, indicating that in COX-2-deficient mice, the contribution of COX-1 to DA closure is gene dosage-dependent. Together, these data establish roles for COX-1, and especially for COX-2, in the transition of the cardiopulmonary circulation at birth.

[1]  L. Muglia,et al.  Inhibition of cyclooxygenase-2 prevents inflammation-mediated preterm labor in the mouse. , 2000, American journal of physiology. Regulatory, integrative and comparative physiology.

[2]  C. Funk,et al.  Insight into prostaglandin, leukotriene, and other eicosanoid functions using mice with targeted gene disruptions. , 1999, Prostaglandins & other lipid mediators.

[3]  A. Guerguerian,et al.  Developmental changes in prostaglandin E(2) receptor subtypes in porcine ductus arteriosus. Possible contribution in altered responsiveness to prostaglandin E(2). , 1999, Circulation.

[4]  D. Zeldin,et al.  Allergic lung responses are increased in prostaglandin H synthase-deficient mice. , 1999, The Journal of clinical investigation.

[5]  W. Wetsel,et al.  Anovulation in Cyclooxygenase-2-Deficient Mice Is Restored by Prostaglandin E2 and Interleukin-1β. , 1999, Endocrinology.

[6]  J. Vane,et al.  Anti-inflammatory drugs and their mechanism of action , 1998, Inflammation Research.

[7]  L. Muglia,et al.  Opposing actions of prostaglandins and oxytocin determine the onset of murine labor. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[8]  S. Narumiya,et al.  Patent ductus arteriosus and neonatal death in prostaglandin receptor EP4-deficient mice. , 1998, Biochemical and biophysical research communications.

[9]  G. C. Smith,et al.  The pharmacology of the ductus arteriosus. , 1998, Pharmacological reviews.

[10]  B. Koller,et al.  The prostaglandin receptor EP4 triggers remodelling of the cardiovascular system at birth , 1997, Nature.

[11]  H. Wiles,et al.  The effect of indomethacin tocolysis on fetal ductus arteriosus constriction with advancing gestational age. , 1997, American journal of obstetrics and gynecology.

[12]  N. Fisk,et al.  Use of a cyclo-oxygenase type-2-selective non-steroidal anti-inflammatory agent to prevent preterm delivery , 1997, The Lancet.

[13]  J. Johnston,et al.  Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II , 1995, Nature.

[14]  R. Langenbach,et al.  Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse , 1995, Cell.

[15]  Hyung-Suk Kim,et al.  Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration , 1995, Cell.

[16]  J. Hobbins,et al.  Fetal Cardiac Function and Ductus Arteriosus During Indomethacin and Sulindac Therapy for Threatened Preterm Labor: A Randomized Study , 1995, American journal of obstetrics and gynecology.

[17]  O. Langer,et al.  Human Placental Transfer of the Prostaglandin Inhibitor Sulindac Using an In Vitro Model , 1995, The Journal of the Society for Gynecologic Investigation: JSGI.

[18]  J. McGrath,et al.  Contractile Effects of Prostanoids on Fetal RabbitDuctus Arteriosus , 1995, Journal of cardiovascular pharmacology.

[19]  R. A. Coleman,et al.  Characterization of dilator prostanoid receptors in the fetal rabbit ductus arteriosus. , 1994, The Journal of pharmacology and experimental therapeutics.

[20]  G. C. Smith,et al.  Characterisation of the effect of oxygen tension on response of fetal rabbit ductus arteriosus to vasodilators. , 1993, Cardiovascular research.

[21]  K. Moise,et al.  Prostaglandin synthetase inhibitors in pregnancy. , 1993, Obstetrical & gynecological survey.

[22]  K. Moise,et al.  Effect of advancing gestational age on the frequency of fetal ductal constriction in association with maternal indomethacin use. , 1993, American journal of obstetrics and gynecology.

[23]  K. Moise,et al.  Placental transfer of indomethacin in the human pregnancy. , 1990, American journal of obstetrics and gynecology.

[24]  D S Sharif,et al.  Indomethacin in the treatment of premature labor. Effects on the fetal ductus arteriosus. , 1988, The New England journal of medicine.

[25]  W. Gersony Patent ductus arteriosus in the neonate. , 1986, The Pediatric clinics of North America.

[26]  J. Vane,et al.  Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. , 1971, Nature: New biology.

[27]  D. Dewitt,et al.  Prostaglandin endoperoxide H synthases-1 and -2. , 1996, Advances in immunology.